nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Ill-defined disorder—Valrubicin—urinary bladder cancer	0.0199	0.0199	CcSEcCtD
Terconazole—Malaise—Valrubicin—urinary bladder cancer	0.0194	0.0194	CcSEcCtD
Terconazole—Myalgia—Valrubicin—urinary bladder cancer	0.0183	0.0183	CcSEcCtD
Terconazole—Discomfort—Valrubicin—urinary bladder cancer	0.0181	0.0181	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.016	0.016	CcSEcCtD
Terconazole—Feeling abnormal—Valrubicin—urinary bladder cancer	0.0145	0.0145	CcSEcCtD
Terconazole—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.0143	0.0143	CcSEcCtD
Terconazole—Influenza like illness—Gemcitabine—urinary bladder cancer	0.0139	0.0139	CcSEcCtD
Terconazole—Pain—Carboplatin—urinary bladder cancer	0.0139	0.0139	CcSEcCtD
Terconazole—Body temperature increased—Valrubicin—urinary bladder cancer	0.0139	0.0139	CcSEcCtD
Terconazole—Abdominal pain—Valrubicin—urinary bladder cancer	0.0139	0.0139	CcSEcCtD
Terconazole—Ill-defined disorder—Mitomycin—urinary bladder cancer	0.0137	0.0137	CcSEcCtD
Terconazole—Malaise—Mitomycin—urinary bladder cancer	0.0134	0.0134	CcSEcCtD
Terconazole—Body temperature increased—Carboplatin—urinary bladder cancer	0.0128	0.0128	CcSEcCtD
Terconazole—Asthenia—Valrubicin—urinary bladder cancer	0.0126	0.0126	CcSEcCtD
Terconazole—Discomfort—Mitomycin—urinary bladder cancer	0.0125	0.0125	CcSEcCtD
Terconazole—Pruritus—Valrubicin—urinary bladder cancer	0.0124	0.0124	CcSEcCtD
Terconazole—Dizziness—Valrubicin—urinary bladder cancer	0.0116	0.0116	CcSEcCtD
Terconazole—Vomiting—Valrubicin—urinary bladder cancer	0.0112	0.0112	CcSEcCtD
Terconazole—Rash—Valrubicin—urinary bladder cancer	0.0111	0.0111	CcSEcCtD
Terconazole—Dermatitis—Valrubicin—urinary bladder cancer	0.0111	0.0111	CcSEcCtD
Terconazole—Headache—Valrubicin—urinary bladder cancer	0.011	0.011	CcSEcCtD
Terconazole—Nausea—Valrubicin—urinary bladder cancer	0.0104	0.0104	CcSEcCtD
Terconazole—Pain—Mitomycin—urinary bladder cancer	0.0103	0.0103	CcSEcCtD
Terconazole—Face oedema—Gemcitabine—urinary bladder cancer	0.01	0.01	CcSEcCtD
Terconazole—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00996	0.00996	CcSEcCtD
Terconazole—Body temperature increased—Mitomycin—urinary bladder cancer	0.00956	0.00956	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Gemcitabine—urinary bladder cancer	0.00937	0.00937	CcSEcCtD
Terconazole—Face oedema—Cisplatin—urinary bladder cancer	0.00936	0.00936	CcSEcCtD
Terconazole—Bronchospasm—Gemcitabine—urinary bladder cancer	0.00885	0.00885	CcSEcCtD
Terconazole—Asthenia—Mitomycin—urinary bladder cancer	0.00867	0.00867	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.008	0.008	CcSEcCtD
Terconazole—Dizziness—Mitomycin—urinary bladder cancer	0.00799	0.00799	CcSEcCtD
Terconazole—Vomiting—Mitomycin—urinary bladder cancer	0.00769	0.00769	CcSEcCtD
Terconazole—Chills—Thiotepa—urinary bladder cancer	0.00768	0.00768	CcSEcCtD
Terconazole—Rash—Mitomycin—urinary bladder cancer	0.00762	0.00762	CcSEcCtD
Terconazole—Dermatitis—Mitomycin—urinary bladder cancer	0.00762	0.00762	CcSEcCtD
Terconazole—Headache—Mitomycin—urinary bladder cancer	0.00757	0.00757	CcSEcCtD
Terconazole—Bronchospasm—Etoposide—urinary bladder cancer	0.00755	0.00755	CcSEcCtD
Terconazole—Nausea—Mitomycin—urinary bladder cancer	0.00718	0.00718	CcSEcCtD
Terconazole—Influenza like illness—Epirubicin—urinary bladder cancer	0.00666	0.00666	CcSEcCtD
Terconazole—Chills—Gemcitabine—urinary bladder cancer	0.00646	0.00646	CcSEcCtD
Terconazole—Arthralgia—Thiotepa—urinary bladder cancer	0.00634	0.00634	CcSEcCtD
Terconazole—Myalgia—Thiotepa—urinary bladder cancer	0.00634	0.00634	CcSEcCtD
Terconazole—Influenza like illness—Doxorubicin—urinary bladder cancer	0.00617	0.00617	CcSEcCtD
Terconazole—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00581	0.00581	CcSEcCtD
Terconazole—Malaise—Gemcitabine—urinary bladder cancer	0.00565	0.00565	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00554	0.00554	CcSEcCtD
Terconazole—Chills—Etoposide—urinary bladder cancer	0.00552	0.00552	CcSEcCtD
Terconazole—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00542	0.00542	CcSEcCtD
Terconazole—Arthralgia—Gemcitabine—urinary bladder cancer	0.00533	0.00533	CcSEcCtD
Terconazole—Myalgia—Gemcitabine—urinary bladder cancer	0.00533	0.00533	CcSEcCtD
Terconazole—Discomfort—Gemcitabine—urinary bladder cancer	0.00527	0.00527	CcSEcCtD
Terconazole—Malaise—Cisplatin—urinary bladder cancer	0.00527	0.00527	CcSEcCtD
Terconazole—Myalgia—Fluorouracil—urinary bladder cancer	0.00525	0.00525	CcSEcCtD
Terconazole—Pain—Thiotepa—urinary bladder cancer	0.0052	0.0052	CcSEcCtD
Terconazole—Discomfort—Fluorouracil—urinary bladder cancer	0.00518	0.00518	CcSEcCtD
Terconazole—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00511	0.00511	CcSEcCtD
Terconazole—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00503	0.00503	CcSEcCtD
Terconazole—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00501	0.00501	CcSEcCtD
Terconazole—Myalgia—Cisplatin—urinary bladder cancer	0.00497	0.00497	CcSEcCtD
Terconazole—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00497	0.00497	CcSEcCtD
Terconazole—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00496	0.00496	CcSEcCtD
Terconazole—Discomfort—Cisplatin—urinary bladder cancer	0.00491	0.00491	CcSEcCtD
Terconazole—Urticaria—Thiotepa—urinary bladder cancer	0.00483	0.00483	CcSEcCtD
Terconazole—Malaise—Etoposide—urinary bladder cancer	0.00483	0.00483	CcSEcCtD
Terconazole—Face oedema—Epirubicin—urinary bladder cancer	0.00481	0.00481	CcSEcCtD
Terconazole—Abdominal pain—Thiotepa—urinary bladder cancer	0.00481	0.00481	CcSEcCtD
Terconazole—Body temperature increased—Thiotepa—urinary bladder cancer	0.00481	0.00481	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00479	0.00479	CcSEcCtD
Terconazole—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00477	0.00477	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00466	0.00466	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00458	0.00458	CcSEcCtD
Terconazole—Discomfort—Etoposide—urinary bladder cancer	0.0045	0.0045	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00448	0.00448	CcSEcCtD
Terconazole—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00448	0.00448	CcSEcCtD
Terconazole—Face oedema—Doxorubicin—urinary bladder cancer	0.00445	0.00445	CcSEcCtD
Terconazole—Pain—Gemcitabine—urinary bladder cancer	0.00437	0.00437	CcSEcCtD
Terconazole—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00437	0.00437	CcSEcCtD
Terconazole—Asthenia—Thiotepa—urinary bladder cancer	0.00436	0.00436	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00434	0.00434	CcSEcCtD
Terconazole—Pruritus—Thiotepa—urinary bladder cancer	0.0043	0.0043	CcSEcCtD
Terconazole—Pain—Fluorouracil—urinary bladder cancer	0.0043	0.0043	CcSEcCtD
Terconazole—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00421	0.00421	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00415	0.00415	CcSEcCtD
Terconazole—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00414	0.00414	CcSEcCtD
Terconazole—Pain—Cisplatin—urinary bladder cancer	0.00408	0.00408	CcSEcCtD
Terconazole—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00404	0.00404	CcSEcCtD
Terconazole—Dizziness—Thiotepa—urinary bladder cancer	0.00402	0.00402	CcSEcCtD
Terconazole—Urticaria—Fluorouracil—urinary bladder cancer	0.00399	0.00399	CcSEcCtD
Terconazole—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00398	0.00398	CcSEcCtD
Terconazole—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00393	0.00393	CcSEcCtD
Terconazole—Vomiting—Thiotepa—urinary bladder cancer	0.00387	0.00387	CcSEcCtD
Terconazole—Rash—Thiotepa—urinary bladder cancer	0.00383	0.00383	CcSEcCtD
Terconazole—Dermatitis—Thiotepa—urinary bladder cancer	0.00383	0.00383	CcSEcCtD
Terconazole—Headache—Thiotepa—urinary bladder cancer	0.00381	0.00381	CcSEcCtD
Terconazole—Body temperature increased—Cisplatin—urinary bladder cancer	0.00377	0.00377	CcSEcCtD
Terconazole—Pain—Etoposide—urinary bladder cancer	0.00373	0.00373	CcSEcCtD
Terconazole—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0037	0.0037	CcSEcCtD
Terconazole—Asthenia—Gemcitabine—urinary bladder cancer	0.00367	0.00367	CcSEcCtD
Terconazole—Pruritus—Gemcitabine—urinary bladder cancer	0.00362	0.00362	CcSEcCtD
Terconazole—Nausea—Thiotepa—urinary bladder cancer	0.00361	0.00361	CcSEcCtD
Terconazole—Feeling abnormal—Etoposide—urinary bladder cancer	0.0036	0.0036	CcSEcCtD
Terconazole—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00357	0.00357	CcSEcCtD
Terconazole—Pruritus—Fluorouracil—urinary bladder cancer	0.00356	0.00356	CcSEcCtD
Terconazole—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00351	0.00351	CcSEcCtD
Terconazole—Urticaria—Etoposide—urinary bladder cancer	0.00347	0.00347	CcSEcCtD
Terconazole—Abdominal pain—Etoposide—urinary bladder cancer	0.00345	0.00345	CcSEcCtD
Terconazole—Body temperature increased—Etoposide—urinary bladder cancer	0.00345	0.00345	CcSEcCtD
Terconazole—Asthenia—Cisplatin—urinary bladder cancer	0.00342	0.00342	CcSEcCtD
Terconazole—Dizziness—Fluorouracil—urinary bladder cancer	0.00333	0.00333	CcSEcCtD
Terconazole—Chills—Methotrexate—urinary bladder cancer	0.0033	0.0033	CcSEcCtD
Terconazole—Vomiting—Gemcitabine—urinary bladder cancer	0.00325	0.00325	CcSEcCtD
Terconazole—Rash—Gemcitabine—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Terconazole—Dermatitis—Gemcitabine—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Terconazole—Hypersensitivity—Etoposide—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Terconazole—Headache—Gemcitabine—urinary bladder cancer	0.0032	0.0032	CcSEcCtD
Terconazole—Vomiting—Fluorouracil—urinary bladder cancer	0.0032	0.0032	CcSEcCtD
Terconazole—Rash—Fluorouracil—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Terconazole—Dermatitis—Fluorouracil—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Terconazole—Headache—Fluorouracil—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Terconazole—Asthenia—Etoposide—urinary bladder cancer	0.00313	0.00313	CcSEcCtD
Terconazole—Chills—Epirubicin—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Terconazole—Pruritus—Etoposide—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Terconazole—Nausea—Gemcitabine—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Terconazole—Vomiting—Cisplatin—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Terconazole—Rash—Cisplatin—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Terconazole—Dermatitis—Cisplatin—urinary bladder cancer	0.003	0.003	CcSEcCtD
Terconazole—Nausea—Fluorouracil—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Terconazole—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00297	0.00297	CcSEcCtD
Terconazole—Malaise—Methotrexate—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Terconazole—Dizziness—Etoposide—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Terconazole—Chills—Doxorubicin—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Terconazole—Nausea—Cisplatin—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Terconazole—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Terconazole—Vomiting—Etoposide—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Terconazole—Rash—Etoposide—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Terconazole—Dermatitis—Etoposide—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Terconazole—Headache—Etoposide—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Terconazole—Arthralgia—Methotrexate—urinary bladder cancer	0.00273	0.00273	CcSEcCtD
Terconazole—Myalgia—Methotrexate—urinary bladder cancer	0.00273	0.00273	CcSEcCtD
Terconazole—Malaise—Epirubicin—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Terconazole—Discomfort—Methotrexate—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Terconazole—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Terconazole—Nausea—Etoposide—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Terconazole—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Terconazole—Myalgia—Epirubicin—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Terconazole—Arthralgia—Epirubicin—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Terconazole—Discomfort—Epirubicin—urinary bladder cancer	0.00252	0.00252	CcSEcCtD
Terconazole—Malaise—Doxorubicin—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Terconazole—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Terconazole—Myalgia—Doxorubicin—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Terconazole—Arthralgia—Doxorubicin—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Terconazole—Discomfort—Doxorubicin—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Terconazole—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Terconazole—Pain—Methotrexate—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Terconazole—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Terconazole—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Terconazole—Pain—Epirubicin—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Terconazole—Urticaria—Methotrexate—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Terconazole—Body temperature increased—Methotrexate—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Terconazole—Abdominal pain—Methotrexate—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Terconazole—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Terconazole—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.002	0.002	CcSEcCtD
Terconazole—Urticaria—Epirubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Terconazole—Pain—Doxorubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Terconazole—Abdominal pain—Epirubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Terconazole—Body temperature increased—Epirubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Terconazole—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Terconazole—Asthenia—Methotrexate—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Terconazole—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Terconazole—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Terconazole—Pruritus—Methotrexate—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Terconazole—Hypersensitivity—Epirubicin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Terconazole—Urticaria—Doxorubicin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Terconazole—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Terconazole—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Terconazole—Asthenia—Epirubicin—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Terconazole—Pruritus—Epirubicin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Terconazole—Dizziness—Methotrexate—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Terconazole—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Terconazole—Vomiting—Methotrexate—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Terconazole—Rash—Methotrexate—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Terconazole—Dermatitis—Methotrexate—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Terconazole—Headache—Methotrexate—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Terconazole—Asthenia—Doxorubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Terconazole—Dizziness—Epirubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Terconazole—Pruritus—Doxorubicin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Terconazole—Vomiting—Epirubicin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Terconazole—Nausea—Methotrexate—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Terconazole—Rash—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Terconazole—Dermatitis—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Terconazole—Headache—Epirubicin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Terconazole—Dizziness—Doxorubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Terconazole—Nausea—Epirubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Terconazole—Vomiting—Doxorubicin—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Terconazole—Rash—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Terconazole—Dermatitis—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Terconazole—Headache—Doxorubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Terconazole—Nausea—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
